The Role of Lipopeptidophosphoglycan in the Immune Response to Entamoeba histolytica

I. Wong-Baeza,M. Alcántara-Hernández,Ismael Mancilla-Herrera,Itzmel Ramírez-Saldívar,L. Arriaga-Pizano,E. Ferat-Osorio,C. López-Macías,A. Isibasi

Published 2010 in Journal of Biomedicine and Biotechnology

ABSTRACT

The sensing of Pathogen Associated Molecular Patterns (PAMPs) by innate immune receptors, such as Toll-like receptors (TLRs), is the first step in the inflammatory response to pathogens. Entamoeba histolytica, the etiological agent of amebiasis, has a surface molecule with the characteristics of a PAMP. This molecule, which was termed lipopeptidophosphoglycan (LPPG), is recognized through TLR2 and TLR4 and leads to the release of cytokines from human monocytes, macrophages, and dendritic cells; LPPG-activated dendritic cells have increased expression of costimulatory molecules. LPPG activates NKT cells in a CD1d-dependent manner, and this interaction limits amebic liver abscess development. LPPG also induces antibody production, and anti-LPPG antibodies prevent disease development in animal models of amebiasis. Because LPPG is recognized by both the innate and the adaptive immune system (it is a “Pamptigen”), it may be a good candidate to develop a vaccine against E. histolytica infection and an effective adjuvant.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-100 of 144 references · Page 1 of 2

CITED BY

Showing 1-38 of 38 citing papers · Page 1 of 1